Osunkeye announced his retirement as chairman of GSK Nigeria yesterday at the 43rd Annual General Meeting (AGM) of the company in
The dividend, which translated into 130 kobo per share, was approved by the shareholders at the AGM.
Speaking on the performance of the company, Osunkeye said GSK Nigeria recorded a revenue growth of 15.3 per cent from N25.3 billion in 2012 to N29.18 billion in 2013.
He attributed the growth in revenue to product development in the consumer healthcare segment and continued sales, marketing and distribution efforts as well as the company's strong presence across
Profit before tax rose from N4.17 billion to N4.31 billion, while profit after tax grew from N2.82 billion to N2.99 billion.
He noted that the company has been able to sustain a steady growth due to the brand equity enjoyed by virtue of its parent company and robust product portfolio.
"The continuous investments and technical assistance from our major shareholder,
"I thank our business partners, distributors, suppliers and service providers without whose support and cooperation the success could not have been achieved," he said.
Osunkeye said GSK will continue to invest in
Meanwhile, the stock market closed on a positive note yesterday as the
Most Popular Stories
- Prosecutor to Investigate Walmart Police Shooting
- Mark Sanchez Suddenly a Hot QB Commodity
- GM to Announce New Jobs in Tennessee
- Chrysler Gets Nod as a Top Employer for Hispanic Women
- Hispanic Entrepreneurs Set Pace in Florida
- Smith & Wesson Misses Target
- Emirates Hit Libyan Targets With Airstrikes
- Laid-off Workers Return to Their Fields
- Marco Rubio Warns Obama on Deportations
- Michael Brown Funeral: Can Americans Change the Script of Violence?